Related Experiment Video
Updated: Aug 12, 2026

08:14
Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial
Published on: September 29, 2015
Pure red cell aplasia associated with fenoprofen
The American Journal of the Medical Sciences
|January 1, 1984
Summary
A patient developed pure red cell aplasia after taking fenoprofen, a nonsteroidal anti-inflammatory drug. Symptoms resolved after discontinuing fenoprofen, highlighting a potential drug-induced anemia.
Area of Science:
- Hematology
- Pharmacology
- Internal Medicine
Background:
- Drug-induced anemias are a recognized adverse effect of various medications.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed for pain and inflammation.
- Pure red cell aplasia (PRCA) is a rare condition characterized by the selective failure of erythropoiesis.
Observation:
- A 69-year-old male patient presented with symptoms suggestive of anemia.
- The patient had been taking fenoprofen, an NSAID, for ten months for an unspecified condition.
- The patient had a history of treated lung carcinoma, which was considered and ruled out as the cause of the anemia.
Findings:
- The patient was diagnosed with pure red cell aplasia (PRCA).
- The erythroid defect completely reversed upon discontinuation of fenoprofen.
- This case is the third reported instance of PRCA associated with an anti-inflammatory agent and the first linked to fenoprofen.
Implications:
- Fenoprofen can induce pure red cell aplasia (PRCA) in susceptible individuals.
- Discontinuation of the offending drug is crucial for the management of drug-induced PRCA.
- This finding expands the spectrum of known adverse hematologic effects associated with NSAIDs.
Related Concept Videos
Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

